This Week at FDA: Year-end guidance drop, counterfeit Ozempic, and more
This Week at FDAFerdous Al-Faruque • Joanne S. Eglovitch • Michael Mezher
Biologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyUnited States